Discover why people like Blair are choosing OCREVUS, proven effective
in relapsing forms of MS and primary progressive MS.
With its 2-times-a-year dosing,* discover why people like Misti are
choosing OCREVUS to treat their relapsing MS or PPMS.
See why Kendra weighed the possible risks and benefits when she was
considering OCREVUS. View the OCREVUS safety profile.
OCREVUS is given as an IV infusion. James and Martha, along with
Jill, a nurse, talk about what to expect on infusion days.
Financial assistance options
There may be options to help you afford your OCREVUS, no matter what
type of health insurance you have.
Stay in touch, stay informed
We're here for you with information-packed emails and resources all
about MS and OCREVUS treatment.